Anika Therapeutics

Anika Therapeutics is a global medical technology company specializing in orthopedic medicines and committed to enhancing patients' lives through innovative therapies for pain management, tissue regeneration, and wound healing. With a focus on treating degenerative orthopedic diseases and traumatic conditions, Anika offers a range of clinically meaningful solutions, including those for osteoarthritis pain, soft tissue repair, and joint preservation. The company's proprietary technology, based on hyaluronic acid, plays a crucial role in promoting joint health and tissue function. Anika's products aim to help individuals feel younger and maintain an active lifestyle through safe, effective, and minimally invasive treatments. Over two decades, Anika has facilitated more than 20 million procedures worldwide, reflecting its commitment to improving patient outcomes and quality of life. The company primarily generates revenue from the United States.

Steve Griffin

CFO

3 past transactions

Parcus Medical

Acquisition in 2020
Parcus Medical, LLC specializes in the design, manufacture, and distribution of surgical implants and instrumentation primarily for orthopedic applications. Founded in 2007, the company offers a diverse range of products, including suture anchors, tenodesis systems, graft fixation systems, interference screws, and various surgical accessories. These products are utilized by orthopedic surgeons in sports medicine procedures aimed at repairing injuries to the shoulder, knee, hip, and distal extremities. Parcus Medical operates from locations in Sarasota, Florida, and Sturgeon Bay, Wisconsin, and is a subsidiary of Anika Therapeutics, Inc.

Arthrosurface

Acquisition in 2020
Arthrosurface, Inc. is an orthopedic medical device company that specializes in minimally invasive joint resurfacing systems. Founded in 2001 and based in Franklin, Massachusetts, the company develops surgical alternatives aimed at treating orthopedic joint diseases, particularly focusing on articular cartilage damage in major joints such as knees, hips, shoulders, and toes. Arthrosurface's product offerings include surface implant curvatures designed to address conditions caused by trauma, injury, and arthritis. The company has introduced a range of products over the years, including resurfacing solutions for the patellofemoral joint, partial knees, and a total shoulder system. By utilizing less invasive technologies, Arthrosurface aims to enable patients to maintain active lifestyles while providing surgeons with innovative tools. Its products are distributed through a network of sales representatives both in the United States and internationally. As of early 2020, Arthrosurface operates as a subsidiary of Anika Therapeutics, Inc.

Fidia Farmaceutici

Acquisition in 2009
Fidia Farmaceutici is an Italian multinational company based in Abano Terme, specializing in the research, development, manufacturing, marketing, and sales of healthcare and pharmaceutical products. The company has a diverse product portfolio primarily focused on hyaluronic acid (HA), which is utilized in various fields including joint care, wound healing, ophthalmology, aesthetics, and autologous biological therapy. Fidia offers a wide range of sterile, lyophilized, and injectable products, as well as ointments, creams, gels, solid oral forms, and eye drops, catering to the pharmaceutical and biomedical sectors with innovative treatments for common medical conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.